


Synuca Therapeutics
Biotechnology Research • Aarhus, Central Denmark Region, Denmark • 1-10 Employees
Company overview
| Headquarters | Aarhus, Central Denmark Region, Denmark |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at Synuca Therapeutics
Lasse Reimer
Chief Executive Officer
Synuca Therapeutics Email Formats
Synuca Therapeutics uses 1 email format. The most common is {2char} (e.g., {2char}@synuca.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{2char} | {2char}@synuca.com | 100% |
About Synuca Therapeutics
Synuca Therapeutics combines decades of groundbreaking research in P-type ATPases and neuroscience from Aarhus University to propose a novel disease-modifying treatment for patients suffering from Parkinson's Disease and associated disorders. By targeting the SERCA calcium transporter, our first-in-class small molecules salvage the root disease cause by repairing the neuronal calcium imbalances caused by pathological α-Synuclein brain species.
Synuca Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | $526,100 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Synuca Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



